Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of HematologyAcute Myeloid Leukemia Working Group

Pinar, Ibrahim EthemCelik, SerhatPolat, Merve GokcenKaratas, Aylin FatmaDogan, AliIltar, UtkuSeval, Guldane Cengiz2024-09-182024-09-1820230006-49711528-0020https://doi.org/10.1182/blood-2023-187351https://hdl.handle.net/20.500.12483/1298265th Annual Meeting of the American-Society-of-Hematology (ASH) -- DEC 09-12, 2023 -- San Diego, CA[Abstract Not Available]eninfo:eu-repo/semantics/openAccessIdarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of HematologyAcute Myeloid Leukemia Working GroupConference Object14210.1182/blood-2023-187351WOS:001159900803125Q1